Welsch M, Bloch J G, Stephan D, Bloch R, Imbs J L
Centre Régional de Pharmacovigilance Alsace et Service d'Hypertension et Maladies vasculaires, Hôpital Civil, Strasbourg.
Therapie. 1990 Sep-Oct;45(5):419-22.
Two new cases of osteofluorosis are presented. They are attested by the existence of a bone X-ray densification, by histological lesions of hyperosteoidosis and a large increase in the fluorine content. One is a 61 year-old man who consumed 2.5 l a day of Vichy St-Yorre (a mineral water containing 8 mg of fluorine ions per litre) during 11 years; the other, an 86 year-old man who during 20 years took 500 mg of niflumic acid a day, a non-steroidal anti-inflammatory drug containing 3 fluorine atoms per molecule (i.e., 50 mg fluorine per 250 mg gellule). Both these hypertensive patients had severe renal insufficiency. These two observations serve as a reminder of the indispensable precautions to be observed when prescribing fluorine salts in the treatment of post-menopausal osteoporosis: at least the plasma creatinine level should be available in order to calculate the endogenous creatinine clearance and any possible supplementary intake of fluorine salts should be checked.
本文报告了两例骨氟中毒新病例。骨X线致密、骨样组织增生的组织学病变以及氟含量大幅增加证实了这两例病例。一例是一名61岁男性,在11年中每天饮用2.5升维希圣约尔矿泉水(一种每升含8毫克氟离子的矿泉水);另一例是一名86岁男性,在20年中每天服用500毫克尼氟灭酸,这是一种每分子含3个氟原子的非甾体抗炎药(即每250毫克胶囊含50毫克氟)。这两名高血压患者均患有严重肾功能不全。这两例观察结果提醒我们,在开氟盐治疗绝经后骨质疏松症时必须采取必要的预防措施:至少应了解血浆肌酐水平以计算内生肌酐清除率,并应检查任何可能额外摄入的氟盐。